InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Discover the detailed record of transactions filed by Passeri Daniel R, 董事长兼首席执行官. Insider active across 2 companies, notably Cue Biopharma, Inc.. Aggregated, 6 filings have been published. Split: 3 buys · 0 sell. Total volume traded: €80k. History available since 24 September 2021. The latest transaction was disclosed on 16 December 2024 (Acquisition). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Daniel R. Passeri is the Chief Executive Officer of Cue Biopharma, Inc. He leads the company, which specializes in the development of biological therapies. His leadership is essential for research and development.